RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$34.03
-3.87%
Mkt Cap $1.33B
Next Earnings
In 9 daysThu, May 7, 2026
EPS Estimate
-$0.62
5 analysts
Revenue Estimate
$7.50M
Last quarter: missed by -10.77% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$1.33B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.30